跳至主要内容
临床试验/NCT05648266
NCT05648266已完成不适用

Serratus Plane Block After Minimally Invasive Mitral Valve Repair

Universitätsklinikum Hamburg-Eppendorf1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2022年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
78
试验地点
1
主要终点
Difference of Numeric Rating Scale after MIC-MKR

研究概览

简要总结

Patients undergoing minimally invasive mitral valve reconstruction via small thoracotomy are randomized into two groups.

The intervention group receives serratus anterior plane block after minimally invasive mitral-valve reconstruction, following 48h infusion with ropivacaine 2% continually.

The control group receives a placebo pump without infusion. Primary endpoints are perceived pain using a numeric pain rating scale and opioid consumption during the hospital stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Planned minimal invasive mitral valve repair via right anterior thoracotomy

排除标准

  • Pregenancy
  • Opioid abuse
  • Historyof chronic pain
  • Allergy to local anaesthetics (in this case ropivacain)
  • Patients who simultaneously participate in another interventional clinical trial, unless the Principal Investigators of the clinical trials give consent by mutual agreement Soft tissue infection in the area of the procedure

研究组 & 干预措施

Continuous SAPB

Active Comparator

postoperative serratus-anterior-plane-block 20ml Ropivacain 0,75%, pain catheter with continous administered Ropivacain (5ml/h 0,2% for 48h)

干预措施: Continous SAPB (Ropivacain) (Drug)

Continuous SAPB

Active Comparator

postoperative serratus-anterior-plane-block 20ml Ropivacain 0,75%, pain catheter with continous administered Ropivacain (5ml/h 0,2% for 48h)

干预措施: institutional standard of care pain medication protocol (Other)

Placebo

Placebo Comparator

standard of care

干预措施: institutional standard of care pain medication protocol (Other)

结局指标

主要结局

Difference of Numeric Rating Scale after MIC-MKR

时间窗: within 12, 24 and 48 hours after surgery

Numeric Rating Scale (0-10, 0=smallest value, 10=greatest value)

次要结局

  • Difference of opioid consumption after MIC-MVR(within 12, 24 and 48 hours after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验